Table 3.
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
adjust OR(95%CI) | P-value | adjust OR(95%CI) | P-value | adjust OR(95%CI) | P-value | |
PLT | ||||||
T1 | 2.002 (1.160–3.454) | 0.013 | 3.887 (1.762–8.575) | 0.001 | 3.517 (1.526–8.106) | 0.003 |
T2 | 1.055 (0.617–1.803) | 0.845 | 1.425 (0.710–2.861) | 0.319 | 1.525 (0.738–3.149) | 0.254 |
T3 | Ref | Ref | Ref | |||
MPV | – | – | 0.714 (0.573–0.890) | 0.003 | 0.698 (0.557–0.875) | 0.002 |
PT | – | – | 3.624 (1.015–12.939) | 0.047 | 3.599 (0.941–13.767) | 0.061 |
INR | – | – | 0.904 (0.796–1.027) | 0.121 | 0.904 (0.791–1.035) | 0.143 |
FIB | – | – | 1.570 (1.191–2.069) | 0.001 | 1.613 (1.199–2.169) | 0.002 |
Notes: Model 1: adjusted sex, age, smoking, drinking, CAD, AF, baseline SBP, NIHSS on admission; Model 2: adjusted for covariates from Model 1 and further adjusted for MPV, PT, INR, FIB and leukocyte counts; Model 3: adjusted for covariates from Model 2 and further adjusted for anticoagulant therapy and antiplatelet therapy
Abbreviations: CI, confidence interval; OR, odds ratio; HT, hemorrhagic transformation; PLT, platelet counts; MPV, mean platelet volume; PT, prothrombin time; INR, International Normalized Ratio; FIB, fibrinogen